• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

MedCap

519.50 SEK+2.87 %16.7, 17.29
Less than 1K followers

MCAP

NASDAQ Stockholm

Investment

Financials

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+2.87 %
+4.99 %
+2.06 %
-0.48 %
-5.37 %
-0.67 %
+96.41 %
+150.97 %
+5,043.56 %

MedCap operates in the investment industry and focuses on long-term equity investments in medical technology and pharmaceutical companies. The company's portfolio includes companies in sectors such as biotechnology and medical technology. The operations are primarily concentrated in Sweden, with a primary presence in the Stockholm region. MedCap was founded in 2001 and is headquartered in Stockholm.

Read more
Market cap
7.83B SEK
Turnover
5.22M SEK
Revenue
2.11B
EBIT %
14.37 %
P/E
35.34
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21.7
2026

Interim report Q2'26

23.10
2026

Interim report Q3'26

5.2
2027

Annual report '26

Regulatory press release26.06.2026, 15.40

MedCap AB (publ) has signed an agreement to acquire Biopsafe ApS in Denmark.

MedCap
Press release05.05.2026, 08.53

Redeye: MedCap (Q1 review): Strong EBITA Growth, Poised for Acquisitions

MedCap
Regulatory press release29.04.2026, 06.30

Strong result; EBITA increased by 30%

MedCap

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11.02.2026, 13.33

Redeye: MedCap (Q4 review): Beat on Solid Organic Growth

MedCap
Regulatory press release06.02.2026, 06.30

Strong results: EBITA increased by 68% for the quarter and 26% for the full year

MedCap
Press release27.10.2025, 14.26

Redeye: MedCap (Q3 review) - Healthy Q3 figures

MedCap
Regulatory press release24.10.2025, 06.30

MedCap AB: Strong organic and acquired growth; EBITA increased by 32%

MedCap
Regulatory press release01.10.2025, 15.00

MedCap AB: Abilia acquires LivAssured

MedCap
Press release23.07.2025, 14.05

Redeye: MedCap Q2 2025 - The rise, fall, and rise again

MedCap
Regulatory press release23.07.2025, 06.30

MedCap AB: Strong quarter with 20 percent EBITA growth and acquisition in Specialty Pharma

MedCap
Regulatory press release21.07.2025, 12.00

MedCap AB: MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma

MedCap
Regulatory press release25.06.2025, 07.30

MedCap AB: MedCap's Business Area Specialty Pharma Acquires XGX Pharma

MedCap
Press release30.04.2025, 07.47

Redeye: MedCap Q1 2025 - Step by step

MedCap
Regulatory press release29.04.2025, 06.30

MedCap AB: 7% growth and EBITA margin recovers to 17%

MedCap
Press release03.02.2025, 08.53

Redeye: MedCap Q4 2024 - A tale of euphoria and despair

MedCap
Regulatory press release31.01.2025, 06.30

MedCap AB: Good demand but unsatisfactory earnings. Strong cash flow.

MedCap
Regulatory press release31.01.2025, 06.30

MedCap AB: MedCap's Business Area Assistive Tech Acquires Danrehab

MedCap
Regulatory press release16.01.2025, 18.30

MedCap AB: Preliminary result for the fourth quarter

MedCap
Press release04.11.2024, 10.24

Redeye: Redeye Initiates Coverage of MedCap

MedCap
Regulatory press release25.10.2024, 06.30

MedCap AB: Profit growth, stronger cash flow and acquisitions

MedCap